Cargando…
Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France
The annual “Antibody Industrial Symposium”, co organized by LabEx MAbImprove, MabDesign and Polepharma, was held in Tours, France on June 27–28, 2017. The focus was on antibody-drug-conjugates (ADCs), new entities which realize the hope of Paul Ehrlich's magic bullet. ADCs result from the bioco...
Autores principales: | Martin, Camille, Kizlik-Masson, Claire, Pèlegrin, André, Watier, Hervé, Viaud-Massuard, Marie-Claude, Joubert, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825198/ https://www.ncbi.nlm.nih.gov/pubmed/29239690 http://dx.doi.org/10.1080/19420862.2017.1412130 |
Ejemplares similares
-
Antibody biosimilars: Fears or opportunities?: First LabEx MAbImprove industrial workshop, May 28, 2013; Tours, France
por: Guillon-Munos, Audrey, et al.
Publicado: (2014) -
MAbImprove: A French “Laboratoire d’excellence” (LabEx) dedicated to therapeutic antibodies
por: Pèlegrin, André, et al.
Publicado: (2014) -
Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6(th) antibody industrial symposium, June 25-26, 2018, Montpellier, France
por: Martineau, Pierre, et al.
Publicado: (2019) -
24th “Nantes Actualités en Transplantation” and 4th “LabEx Immunotherapy-Graft-Oncology” NAT and IGO Joint Meeting “New Horizons in Immunotherapy”
por: Joalland, Noémie, et al.
Publicado: (2021) -
Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012
por: Desoubeaux, Guillaume, et al.
Publicado: (2013)